Papers
4
Total Citations
28
H-Index
3
About
Dukagjin Blakaj is a radiation oncologist whose research focuses on optimizing treatment strategies for head and neck cancers, particularly through the integration of trans-oral robotic surgery (TORS) and adjuvant therapies. His work has been instrumental in identifying clinical and socioeconomic predictors that guide adjuvant therapy decisions after TORS for oropharyngeal squamous cell carcinoma, a critical factor in reducing the need for multimodality treatment and improving patient outcomes. Notably, his 2020 study on this topic has garnered 13 citations, reflecting its impact on clinical practice. Blakaj also highlighted the risks of omitting adjuvant radiotherapy, showing an increased likelihood of retropharyngeal node recurrence in head and neck cancer patients after TORS—a finding with 9 citations that underscores the importance of comprehensive treatment planning. Beyond head and neck oncology, he has contributed to advances in stereotactic radiosurgery for multiple brain metastases, demonstrating the safety and efficacy of single-isocenter multitarget approaches, and has explored robotic-assisted brachytherapy for pelvic recurrences. His work bridges surgical innovation and radiation oncology, offering evidence-based insights that shape modern cancer care.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4